Exabis Library
Welcome to the e-CCO Library!
P108: Identifying Patient-Centered Future Research Priorities: A Report from the Patient Reported Outcomes after Pouch Surgery (PROPS) Delphi Consensus Study
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P108: Oleuropein decreases interleukin-17 and attenuates inflammatory damage in colonic mucosa from ulcerative colitis patients
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P108: Validation of a new score for paediatric Crohn's disease on a paediatric tertiary hospital: the MINI-Index (Mucosal Inflammation Non-Invasive Index)
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P109 Construction of a suite of computable biological network models focused on inflammatory bowel disease
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P109: Analysis of the clinical, gastroscopic, and pathological features of upper gastrointestinal lesions in Crohn’s disease
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P109: Effect of dysbiosis on the growth and colitis susceptibility in DSS colitis model
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P109: Impact of ethnicity on colorectal cancer incidence in a cohort of colitis-associated dysplasia patients
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P109: Profiling of receptor for advanced glycation end products expression in cases of primary sclerosing cholangitis with ulcerative colitis
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P109: Rifaximin and Saccharomyces boulardii increase stress resilience in TNBS-induced colitis
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P109: Risk of cervical cancer in incident Ulcerative Colitis during the first 10 years after diagnosis: A nationwide population-based study
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P109: Using baseline Peripheral blood mononuclear cell (PBMC) transcriptomics of Crohn Disease patients receiving Ustekinumab treatment as a tool to assess potential response at 1 year
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:48 AM
P110 Identification of the tryptophan metabolite 3-hydroxyanthranilic acid as a novel tool for the differentiation of Crohn’s disease phenotypes
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P110: Characterization of human intestinal macrophage subsets in health and inflammatory bowel disease
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P110: Cigarette smoke modulates the effect of dextran sulfate sodium–induced colitis on a subpopulation of T-cells in blood and colon in mice
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P110: Fibroblast activation protein is strongly expressed in intestinal fibrosis in inflammatory bowel disease patients
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:48 AM
P110: Inter-rater validity of a new scoring index for Crohn’s disease (Crohn's disease activity in capsule endoscopy)
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P110: Risk Factors of Clinical Relapses in Pediatric Luminal Crohn’s Disease, a Retrospective Cohort Study
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P110: Symptomology and most bothersome symptoms among pediatric Crohn’s disease and ulcerative colitis patients: Results from a physician and patient survey
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P110: TIGIT expression identifies circulating CD38+ effector T cells with immune regulatory properties whose frequencies at diagnosis predict disease course of paediatric IBD patients
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM